176 related articles for article (PubMed ID: 30325974)
21. Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer.
Kojima K; Nakamura T; Ooizumi Y; Igarashi K; Tanaka T; Yokoi K; Ishii S; Nishizawa N; Katoh H; Kosaka Y; Sato T; Watanabe M; Yamashita K
PLoS One; 2019; 14(1):e0211108. PubMed ID: 30677088
[TBL] [Abstract][Full Text] [Related]
22. DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer.
Ushiku H; Yamashita K; Ema A; Minatani N; Kikuchi M; Kojo K; Yokoi K; Tanaka T; Nishizawa N; Ishii S; Hosoda K; Moriya H; Mieno H; Katada N; Kikuchi S; Katoh H; Watanabe M
Gastric Cancer; 2017 Sep; 20(5):784-792. PubMed ID: 28243814
[TBL] [Abstract][Full Text] [Related]
23. Perineural invasion and preoperative serum CA19-9 as predictors of survival in biliary tract cancer.
Kawamata H; Yamashita K; Nakamura K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Kumamoto Y; Watanabe M
Anticancer Res; 2013 Feb; 33(2):583-94. PubMed ID: 23393352
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma.
Kwon J; Park M; Kim JH; Lee HW; Kang MC; Park JH
Tumour Biol; 2015 Sep; 36(10):7449-56. PubMed ID: 25903467
[TBL] [Abstract][Full Text] [Related]
25. Novel target genes and a valid biomarker panel identified for cholangiocarcinoma.
Andresen K; Boberg KM; Vedeld HM; Honne H; Hektoen M; Wadsworth CA; Clausen OP; Karlsen TH; Foss A; Mathisen O; Schrumpf E; Lothe RA; Lind GE
Epigenetics; 2012 Nov; 7(11):1249-57. PubMed ID: 22983262
[TBL] [Abstract][Full Text] [Related]
26. BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma.
Li J; Yang Z; Huang S; Li D
Technol Cancer Res Treat; 2020; 19():1533033820971676. PubMed ID: 33234031
[TBL] [Abstract][Full Text] [Related]
27. [The Role of Plasma CDO1 Methylation in the Early Diagnosis of Lung Cancer].
Wang P; Zhao H; Shi R; Liu X; Liu J; Ren F; Zhao Q; Zhang H; Li Y; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):314-320. PubMed ID: 32317090
[TBL] [Abstract][Full Text] [Related]
28. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
29. Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cells.
Yang J; Sun L; Liu XY; Huang C; Peng J; Zeng X; Zheng H; Cen W; Xu YX; Zhu W; Wu XY; Ling D; Zhang LL; Wei M; Liu Y; Wang D; Wang FH; Li YH; Li Q; Du Z
Clin Transl Med; 2023 Sep; 13(9):e1423. PubMed ID: 37740473
[TBL] [Abstract][Full Text] [Related]
30. Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.
Han Y; Zhang W; Liu Y
World J Surg; 2013 Oct; 37(10):2419-27. PubMed ID: 23793608
[TBL] [Abstract][Full Text] [Related]
31. [Expression of Survivin protein in extrahepatic cholangiocarcinoma and its relationship with the prognosis].
Qin XL; Xue HZ; Wang ZR; Liu HS; Zhou HB; Ma W
Zhonghua Wai Ke Za Zhi; 2009 Dec; 47(24):1852-6. PubMed ID: 20193400
[TBL] [Abstract][Full Text] [Related]
32. Promoter hypermethylation of cysteine dioxygenase type 1 in patients with non-small cell lung cancer.
Yin W; Wang X; Li Y; Wang B; Song M; Hulbert A; Chen C; Yu F
Oncol Lett; 2020 Jul; 20(1):967-973. PubMed ID: 32566027
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer.
Yamashita S; Passot G; Aloia TA; Chun YS; Javle M; Lee JE; Vauthey JN; Conrad C
Br J Surg; 2017 Feb; 104(3):267-277. PubMed ID: 28052308
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic biomarkers of promoter DNA methylation in the new era of cancer treatment.
Yamashita K; Hosoda K; Nishizawa N; Katoh H; Watanabe M
Cancer Sci; 2018 Dec; 109(12):3695-3706. PubMed ID: 30264476
[TBL] [Abstract][Full Text] [Related]
35. DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract.
Uhl B; Dietrich D; Branchi V; Semaan A; Schaefer P; Gevensleben H; Rostamzadeh B; Lingohr P; Schäfer N; Kalff JC; Kristiansen G; Matthaei H
PLoS One; 2016; 11(10):e0165769. PubMed ID: 27798672
[TBL] [Abstract][Full Text] [Related]
36. Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.
Harada H; Soeno T; Nishizawa N; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
Cancer Sci; 2021 Apr; 112(4):1644-1654. PubMed ID: 33576114
[TBL] [Abstract][Full Text] [Related]
37. Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines.
Jeschke J; O'Hagan HM; Zhang W; Vatapalli R; Calmon MF; Danilova L; Nelkenbrecher C; Van Neste L; Bijsmans IT; Van Engeland M; Gabrielson E; Schuebel KE; Winterpacht A; Baylin SB; Herman JG; Ahuja N
Clin Cancer Res; 2013 Jun; 19(12):3201-11. PubMed ID: 23630167
[TBL] [Abstract][Full Text] [Related]
38. Comparison of ADAM19 and CUEDC2 expression in EHCC and their clinicopathological significance.
Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
Biomark Med; 2020 Nov; 14(16):1573-1584. PubMed ID: 32960074
[No Abstract] [Full Text] [Related]
39. Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma.
Choi JI; Cho EH; Kim SB; Kim R; Kwon J; Park M; Shin HJ; Ryu HS; Park SH; Lee KH
Ann Hepatobiliary Pancreat Surg; 2017 Nov; 21(4):181-187. PubMed ID: 29264579
[TBL] [Abstract][Full Text] [Related]
40. Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non-Small Cell Lung Cancer.
Liu B; Ricarte Filho J; Mallisetty A; Villani C; Kottorou A; Rodgers K; Chen C; Ito T; Holmes K; Gastala N; Valyi-Nagy K; David O; Gaba RC; Ascoli C; Pasquinelli M; Feldman LE; Massad MG; Wang TH; Jusue-Torres I; Benedetti E; Winn RA; Brock MV; Herman JG; Hulbert A
Clin Cancer Res; 2020 Aug; 26(16):4339-4348. PubMed ID: 32430478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
